Deutsch
Español
India
Italiano
Français
My Account
My Account
Notifications
Overview
+ New Watchlist
Benzinga Research
Benzinga Pro
Log In
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
Get Benzinga Pro
Data & APIs
Events
Marketfy
Premarket
Boost
Advertise
Contribute
Deutsch
Español
India
Italiano
Français
Sign in
Our Services
News
Earnings
Guidance
Dividends
M&A
Buybacks
Legal
Interviews
Management
Offerings
IPOs
Insider Trades
Biotech/FDA
Politics
Government
Healthcare
Markets
Pre-Market
After Hours
Movers
ETFs
Forex
Cannabis
Commodities
Options
Binary Options
Bonds
Futures
CME Group
Global Economics
Previews
Small-Cap
Real Estate
Cryptocurrency
Penny Stocks
Digital Securities
Volatility
Ratings
Analyst Color
Downgrades
Upgrades
Initiations
Price Target
Ideas
Trade Ideas
Covey Trade Ideas
Long Ideas
Short Ideas
Technicals
From The Press
Jim Cramer
Rumors
Best Stocks & ETFs
Best Penny Stocks
Best S&P 500 ETFs
Best Swing Trade Stocks
Best Blue Chip Stocks
Best High-Volume Penny Stocks
Best Small Cap ETFs
Best Stocks to Day Trade
Best REITs
Money
Investing
Cryptocurrency
Mortgage
Insurance
Yield
Personal Finance
Forex
Startup Investing
Real Estate Investing
Credit Cards
Crypto
Cannabis
Cannabis Conference
News
Earnings
Interviews
Deals
Regulations
Psychedelics
Jobs
Markets
Pre-Market
After Hours
Movers
ETFs
Forex
Cannabis
Commodities
Options
Binary Options
Bonds
Futures
CME Group
Global Economics
Previews
Small-Cap
Real Estate
Cryptocurrency
Penny Stocks
Digital Securities
Volatility
Ratings
Analyst Color
Downgrades
Upgrades
Initiations
Price Target
Ideas
Trade Ideas
Covey Trade Ideas
Long Ideas
Short Ideas
Technicals
From The Press
Jim Cramer
Rumors
Best Stocks & ETFs
Best Penny Stocks
Best S&P 500 ETFs
Best Swing Trade Stocks
Best Blue Chip Stocks
Best High-Volume Penny Stocks
Best Small Cap ETFs
Best Stocks to Day Trade
Best REITs
Money
Investing
Cryptocurrency
Mortgage
Insurance
Yield
Personal Finance
Forex
Startup Investing
Real Estate Investing
Credit Cards
Crypto
Cannabis
Cannabis Conference
News
Earnings
Interviews
Deals
Regulations
Psychedelics
Jobs
Research
My Stocks
Tools
Free Benzinga Pro Trial
Calendars
Analyst Ratings Calendar
Conference Call Calendar
Dividend Calendar
Earnings Calendar
Economic Calendar
FDA Calendar
Guidance Calendar
IPO Calendar
M&A Calendar
SPAC Calendar
Stock Split Calendar
Trade Ideas
Free Stock Reports
Insider Trades
Trade Idea Feed
Analyst Ratings
Unusual Options Activity
Heatmaps
Free Newsletter
Government Trades
Short Interest
Most Shorted
Largest Increase
Largest Decrease
Calculators
Margin Calculator
Forex Profit Calculator
100x Options Profit Calculator
Recent
Markets
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
Champion Industries
(OTCEM:CHMP)
Intraday
$0.0001
0
[0.00%]
Get Report
Watch
Perks
Buy
Compare Brokers
$0.0001
0
[0.00%]
At close: Oct 13
Get Report
Watch
Overview
News
Earnings
Guidance
Dividends
Analyst Ratings
Insider Trades
Short Interest
Latest News for Champion Industries Stock (OTC:CHMP)
Champion Industries Stock (OTC: CHMP)
Categories: All
All News
General
Contracts
Dividends
Events
FDA
M&A
Offerings
Stock Split
Media
Buybacks
Insider Trades
Earnings
Guidance
Analyst Ratings
Trading Ideas
All News
General
Contracts
Dividends
Events
FDA
M&A
Offerings
Stock Split
Media
Buybacks
Insider Trades
Earnings
Guidance
Analyst Ratings
Trading Ideas
Friday, March 01, 2019
CHMP Recommends Lexicon And Sanofi's Zynquista For The Treatment Of Adults With Type 1 Diabetes
Benzinga Newsdesk
-
Mar 1, 2019, 8:01AM
Friday, September 14, 2012
Champion Industries /WV Reports Q3 EPS $-0.10
Benzinga
-
Sep 14, 2012, 4:01PM
Friday, February 17, 2012
Abbott Receives Positive Opinion for HUMIRA in Ulcerative Colitis from EMA's CHMP
Benzinga
-
Feb 17, 2012, 7:56AM
CHMP Recommends Approval of BYETTA for Use With Basal Insulin
Benzinga
-
Feb 17, 2012, 7:55AM
Monday, February 13, 2012
Alexza Pharmaceuticals Receives Day 80 Assessment Report for ADASUVE MAA
Benzinga
-
Feb 13, 2012, 8:04AM
Monday, January 30, 2012
Allos Therapeutics Requests Re-Examination of CHMP Opinion on FOLOTYN in PTCL at the European Medicines Agency
Benzinga
-
Jan 30, 2012, 8:30AM
Friday, September 09, 2011
Champion Reports Q3 EPS $0.09 vs ($0.07) Prior; Revenue $32M vs 33.17M Est
Benzinga
-
Sep 9, 2011, 4:02PM
Monday, May 23, 2011
UPDATE: Piper Jaffray Upgrading Acorda Therapeutics
Benzinga
-
May 23, 2011, 7:33AM
Friday, January 28, 2011
Cloud Computing Deal with Verizon and Terremark Creates Top Trader for Investors
Benzinga
-
Jan 28, 2011, 12:48PM
Vaccines Pull Down NVS Q4 Earnings - Analyst Blog
Benzinga
-
Jan 28, 2011, 10:31AM
Vaccines Pull Down NVS Q4 Earnings - Analyst Blog
Benzinga
-
Jan 28, 2011, 10:15AM
Novartis to Buy Genoptix - Analyst Blog
Benzinga
-
Jan 28, 2011, 8:40AM
Novartis to Buy Genoptix - Analyst Blog
Benzinga
-
Jan 28, 2011, 8:15AM
Wednesday, January 26, 2011
CHMP Stands Negative on MKGAF Drug - Analyst Blog
Benzinga
-
Jan 26, 2011, 9:08AM
CHMP Stands Negative on MKGAF Drug - Analyst Blog
Benzinga
-
Jan 26, 2011, 8:15AM
Tuesday, January 25, 2011
Boost for VRX-GSK Epilepsy Drug - Analyst Blog
Benzinga
-
Jan 25, 2011, 10:01AM
Boost for VRX-GSK Epilepsy Drug - Analyst Blog
Benzinga
-
Jan 25, 2011, 9:45AM
Monday, January 24, 2011
Biogen-Acorda MS Drug Faces Setback - Analyst Blog
Benzinga
-
Jan 24, 2011, 12:31PM
Biogen-Acorda MS Drug Faces Setback - Analyst Blog
Benzinga
-
Jan 24, 2011, 11:45AM
Thursday, January 13, 2011
Lucentis Gains EU Approval for DME - Analyst Blog
Benzinga
-
Jan 13, 2011, 8:46AM
Lucentis Gains EU Approval for DME - Analyst Blog
Benzinga
-
Jan 13, 2011, 8:00AM
Monday, December 20, 2010
ITMN's Esbriet Backed for EU Nod - Analyst Blog
Benzinga
-
Dec 20, 2010, 12:30PM
ITMN's Esbriet Backed for EU Nod - Analyst Blog
Benzinga
-
Dec 20, 2010, 12:00PM
Friday, December 17, 2010
InterMune Continues To Skyrocket (ITMN)
Benzinga
-
Dec 17, 2010, 2:57PM
Top Narrow Based Indexes For December 17 (ITMN, SMI, HSFT)
Benzinga
-
Dec 17, 2010, 11:03AM
Morning Market Movers (ITMN, BASI, NYMX, MI)
Benzinga
-
Dec 17, 2010, 10:25AM
Benzinga's Top Pre-Market NASDAQ Gainers (ITMN, YRCW, TTWO, ORCL)
Benzinga
-
Dec 17, 2010, 8:26AM
Monday, November 29, 2010
Merck KGaA MS Drug Faces Glitch - Analyst Blog
Benzinga
-
Nov 29, 2010, 3:30PM
Merck KGaA MS Drug Faces Glitch - Analyst Blog
Benzinga
-
Nov 29, 2010, 10:18AM
Tuesday, September 28, 2010
Positive EU Opinion for AZN Drug - Analyst Blog
Benzinga
-
Sep 28, 2010, 12:03AM
Friday, September 10, 2010
Champion Reports Results for 3rd Quarter
Benzinga
-
Sep 10, 2010, 4:05PM
Wednesday, September 08, 2010
Earnings Scheduled For September 8 (SFD, CIEN, MW, DFZ, TLB, UNFI, AVAV, TITN, RURL, CHMP, HITK, JTX, NAV, NTWK, REX, STRM)
Benzinga
-
Sep 8, 2010, 5:51AM
Tuesday, September 07, 2010
Gilead Files MAA for HIV Drug - Analyst Blog
Benzinga
-
Sep 7, 2010, 5:03PM
Friday, August 27, 2010
European Approval for Shire Drug - Analyst Blog
Benzinga
-
Aug 27, 2010, 5:33PM
Friday, August 20, 2010
Before The Bell – A Glimpse Of The Market Today
Benzinga
-
Aug 20, 2010, 8:36AM
US Stock Futures Face Dismal Day Again
Benzinga
-
Aug 20, 2010, 7:21AM
Earnings Scheduled For August 20 (SJM, ANN, HRL, COCO, KIRK, CHMP, MTRX, HIBB)
Benzinga
-
Aug 20, 2010, 6:10AM
Friday, July 16, 2010
Glaxo's Avandia Backed by FDA - Analyst Blog
Benzinga
-
Jul 16, 2010, 1:21PM
Monday, July 12, 2010
Testing Times for Glaxo's Avandia - Analyst Blog
Benzinga
-
Jul 12, 2010, 3:30PM
Monday, June 28, 2010
Good News for Shire - Analyst Blog
Benzinga
-
Jun 28, 2010, 10:21AM
Benzinga’s Top Pre-Market Losers (FFCH, MTXX, AMZN, SHPGY)
Benzinga
-
Jun 28, 2010, 8:51AM
Tuesday, June 01, 2010
Zacks Analyst Blog Highlights: Ford Motor, General Motor, Tata Motors, Amgen and GlaxoSmithKline - Press Releases
Benzinga
-
Jun 1, 2010, 8:07AM
Friday, May 28, 2010
EU Approval for Amgen's Prolia - Analyst Blog
Benzinga
-
May 28, 2010, 5:45PM
Wednesday, April 28, 2010
Zacks Analyst Blog Highlights: United States Steel Corporation, Merck, Forest Laboratories, GlaxoSmithKline and Pfizer - Press Releases
Benzinga
-
Apr 28, 2010, 8:30AM
Tuesday, April 27, 2010
Merck Acquires Daxas Rights - Analyst Blog
Benzinga
-
Apr 27, 2010, 10:00AM
Thursday, April 22, 2010
Conditional Approval for Glaxo Drug - Analyst Blog
Benzinga
-
Apr 22, 2010, 11:00AM
Monday, April 19, 2010
Additional Indication for OSI Drug - Analyst Blog
Benzinga
-
Apr 19, 2010, 5:46PM
Wednesday, March 31, 2010
NVS Wins Approval for Vaccine - Analyst Blog
Benzinga
-
Mar 31, 2010, 12:16PM
Monday, March 22, 2010
Good News for OSI Pharma - Analyst Blog
Benzinga
-
Mar 22, 2010, 2:08PM
Friday, March 19, 2010
Benzinga’s News Roundup (NXY, PALM, TTEK, PERY, OSIP)
Benzinga
-
Mar 19, 2010, 8:48AM
Show more